From an anal PrEP douche to the first women-controlled HIV prevention product, here's all the new HIV prevention products ...
Lenacapavir is a long-acting pre-exposure prophylaxis (PrEP) product, a treatment that works by stopping HIV from getting ...
From an anal PrEP douche to the first women-controlled HIV prevention product, here's all the new HIV prevention products ...
News Medical on MSN1h
Affordability and supply remain critical to the success of long-lasting HIV drugAffordability and mass distribution will be critical to the success of a long-lasting injectable HIV prevention drug that has ...
From oral PrEP, to injectables, rings, and implants, this year's HIV Research for Prevention conference was all about options ...
With just 15 days until the presidential election, the federal government is proposing new rules that aim to bolster ...
The number of HIV diagnoses in the Netherlands is no longer falling and infections are on the rise among young men, according ...
The Dutch Aids foundation Aidsfonds says it is concerned about the rise in cases of HIV in young men who have sex with men.
News Medical on MSN22h
Sweden exceeds UNAIDS HIV goals but faces new challengesSweden has surpassed the UNAIDS 95-95-95 targets, with reduced HIV incidence and a steady increase in diagnosed and treated ...
Zacks.com on MSN8h
Gilead, MRK Report Data From Investigational Combination Study for HIVGilead Sciences, Inc. GILD and partner Merck MRK announced new results from a mid-stage study evaluating the investigational ...
On September 10, experts across disciplines, from infectious disease clinicians to regulators to representatives from the pharmaceutical industry, convened at the inaugural ImmunOptimize workshop in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback